Infection Prevention and Enteral Access

Infection Prevention and Enteral Access Market Outlook

The global Infection Prevention and Enteral Access Market is projected to reach a valuation of approximately $12 billion by 2035, growing at a robust compound annual growth rate (CAGR) of around 9% during the forecast period of 2025 to 2035. This growth can be attributed to several key factors, including the rising prevalence of chronic diseases that require enteral feeding, advancements in healthcare technology, and an increasing emphasis on infection prevention protocols in hospitals and healthcare facilities. Furthermore, the aging population is expected to contribute significantly to the demand for enteral access solutions, as older adults often suffer from conditions that necessitate nutritional support through enteral feeding. Additionally, the growing awareness of the importance of infection control measures and the adoption of stringent healthcare regulations are driving market expansion, fostering innovations in product development, and generating a demand for safer, more effective enteral access devices.

Growth Factor of the Market

The Infection Prevention and Enteral Access Market is primarily driven by the increasing incidence of conditions such as dysphagia, neurological disorders, and certain cancers, which require enteral feeding for nutritional support. Technological advancements in enteral feeding devices are also a significant contributor, enhancing the efficiency, safety, and ease of use of these products. The heightened focus on infection prevention, fueled by the ongoing threat of healthcare-associated infections (HAIs), has led to the development of innovative antimicrobial products that improve patient outcomes and reduce complications. Additionally, the expansion of healthcare infrastructure in emerging economies is creating new opportunities for market players to introduce advanced enteral access products. The rise of home healthcare services, driven by the growing preference for at-home medical care, is further propelling the demand for enteral feeding solutions, as patients seek to manage their health conditions outside traditional healthcare settings.

Key Highlights of the Market

• The global Infection Prevention and Enteral Access Market is on track to reach approximately $12 billion by 2035.
• The market is projected to grow at a CAGR of around 9% during the forecast period from 2025 to 2035.
• Technological advancements in enteral feeding devices are driving market growth.
• The aging population is contributing significantly to the demand for enteral access solutions.
• There is a growing emphasis on stringent infection control measures in healthcare facilities.

By Product Type

Antimicrobial Catheters:

Antimicrobial catheters are designed to reduce the risk of infections commonly associated with indwelling catheters. These specialized devices are coated with antimicrobial agents that inhibit the growth of bacteria and other pathogens, making them essential in infection prevention protocols. The demand for antimicrobial catheters is on the rise, particularly in hospitals and long-term care facilities where the risk of healthcare-associated infections is significantly high. As healthcare professionals continue to prioritize patient safety, the adoption of antimicrobial catheters has gained traction, reflecting the ongoing commitment to improving clinical outcomes and minimizing complications related to catheter use.

Enteral Feeding Pumps:

Enteral feeding pumps facilitate the administration of liquid nutrition directly into the gastrointestinal (GI) tract, providing a crucial lifeline for patients unable to consume food orally. These pumps are engineered for precision and reliability, allowing healthcare providers to deliver controlled amounts of enteral formulas over extended periods. The growing prevalence of conditions that impair swallowing or digestion is driving the demand for enteral feeding pumps. Moreover, advancements in pump technology, including features such as alarm systems and programmable settings, are enhancing patient safety and convenience, further solidifying their position in the market.

Enteral Feeding Tubes:

Enteral feeding tubes are vital medical devices that enable the delivery of nutrition to patients with swallowing disorders or those recovering from surgery. These tubes come in various sizes and materials, including silicone and polyurethane, tailored for different patient needs and clinical scenarios. The increasing incidence of chronic diseases, such as stroke and neurological disorders, is boosting the demand for enteral feeding tubes, as more patients require nutritional support. Additionally, innovations in tube design, including features that enhance patient comfort and ease of insertion, are driving market growth and improving overall patient care.

Enteral Feeding Accessories:

Enteral feeding accessories, including connector systems, syringes, and adapters, play a crucial role in ensuring the safe and effective delivery of enteral nutrition. These products are designed to enhance the functionality of enteral feeding systems, enabling healthcare providers to administer nutrition with minimal risk of contamination or errors. The rise in home healthcare settings has increased the demand for enteral feeding accessories, as patients and caregivers seek reliable solutions to manage feeding at home. With ongoing advancements in accessory design and materials, the market for these products is expected to witness significant growth in the coming years.

Enteral Feeding Formulas:

Enteral feeding formulas provide essential nutrients to patients unable to meet their dietary needs through normal consumption. These formulas are specifically formulated to support various medical conditions, including malnutrition, chronic illness, and recovery from surgery. The growing awareness of the importance of nutritional support in patient care is driving the demand for enteral feeding formulas. Additionally, the availability of specialized formulas designed to meet the unique needs of different patient populations, such as those with diabetes or renal issues, is expanding the market. As healthcare providers increasingly recognize the critical role of nutrition in recovery and overall health, the demand for high-quality enteral feeding formulas continues to rise.

By Application

Hospitals:

Hospitals represent one of the largest segments in the Infection Prevention and Enteral Access Market, as they are the primary settings for acute care and patient management. Within hospitals, enteral access is frequently employed to provide nutrition to critically ill patients or those undergoing surgery. The increasing focus on infection control in hospital environments drives the adoption of advanced enteral access devices, including antimicrobial catheters and enteral feeding pumps. Moreover, the growing recognition of the importance of early enteral feeding in improving patient outcomes is further propelling the demand for these solutions within hospital settings.

Ambulatory Surgical Centers:

Ambulatory surgical centers (ASCs) are gaining prominence in the Infection Prevention and Enteral Access Market, as they provide a cost-effective alternative to traditional hospital settings for surgical procedures. The need for enteral access solutions in ASCs is primarily driven by the growing number of outpatient surgeries and the rising prevalence of patients requiring nutritional support. With the emphasis on minimizing hospital visits and associated infection risks, ASCs are increasingly adopting enteral feeding devices and accessories to cater to their patient base. This trend is expected to continue as healthcare systems increasingly shift towards outpatient care models.

Long-term Care Facilities:

Long-term care facilities, including nursing homes and assisted living residences, represent a significant application segment in the Infection Prevention and Enteral Access Market. The rising population of elderly individuals requiring continual medical and nutritional support in these settings is contributing to the demand for enteral access solutions. Enteral feeding is often necessary for patients with swallowing difficulties or chronic illnesses, and long-term care facilities are increasingly adopting advanced products to enhance patient comfort and safety. The emphasis on infection prevention in these facilities further drives the need for antimicrobial devices and accessories, as healthcare providers strive to minimize the risk of complications.

Home Care Settings:

Home care settings have emerged as a rapidly growing segment within the Infection Prevention and Enteral Access Market. As patients increasingly prefer receiving care in the comfort of their own homes, there has been a significant uptick in demand for enteral feeding solutions tailored for at-home use. This trend is driven by the increased prevalence of chronic diseases and the aging population, leading to a greater need for ongoing nutritional support. Home care providers are actively seeking safe and effective enteral feeding devices, emphasizing user-friendly designs that allow caregivers to manage feeding with minimal complications. The convenience and flexibility offered by home care solutions are poised to drive substantial market growth in this area.

Clinics:

Clinics, including outpatient and specialized medical facilities, are increasingly implementing enteral access solutions to cater to patients requiring nutritional support. The rising prevalence of conditions leading to dysphagia and the need for enteral feeding in outpatient settings is driving this trend. Clinics are adopting a range of enteral feeding products, from tubes to feeding formulas, to ensure they can provide comprehensive care for their patients. The growing emphasis on preventive healthcare and the management of chronic diseases in clinical settings is further propelling the demand for enteral access solutions, as healthcare providers strive to enhance patient outcomes through effective nutritional support.

By Distribution Channel

Hospitals Pharmacies:

Hospital pharmacies play a pivotal role in the distribution of infection prevention and enteral access products, as they ensure that healthcare facilities have immediate access to essential devices and supplies. These pharmacies are responsible for managing a wide range of medical products, including antimicrobial catheters and enteral feeding tubes, ensuring that they are readily available for clinical use. The increasing focus on infection control and patient safety within hospitals has led to a greater emphasis on acquiring high-quality enteral access solutions through hospital pharmacies, which are often preferred due to their ability to provide specialized products tailored for hospital settings.

Retail Pharmacies:

Retail pharmacies are becoming increasingly important in the Infection Prevention and Enteral Access Market, particularly as patients seek to manage their healthcare needs more independently. The demand for enteral feeding products in retail settings has risen, driven by the growing prevalence of home healthcare and the need for patients to acquire necessary supplies for at-home feeding. Retail pharmacies are expanding their offerings to include a variety of enteral feeding devices and accessories, catered towards patients who may not have access to specialized suppliers. The convenience of obtaining enteral products at retail pharmacies is appealing to patients and caregivers, further enhancing market growth.

Online Pharmacies:

Online pharmacies have emerged as a significant distribution channel within the Infection Prevention and Enteral Access Market, providing patients and healthcare professionals with convenient access to a wide range of enteral feeding products. The growing trend of e-commerce in healthcare is driven by the increasing demand for convenience and the ability to compare products easily. Online pharmacies offer a broad selection of enteral feeding devices, accessories, and formulas that can be delivered directly to patients' homes, addressing the needs of those requiring ongoing nutritional support. As online healthcare shopping continues to gain traction, the role of online pharmacies in facilitating access to enteral access solutions is expected to expand significantly.

Others:

Other distribution channels, which may include specialty medical supply stores and direct sales from manufacturers, also contribute to the Infection Prevention and Enteral Access Market. These channels provide alternative means for healthcare facilities and patients to access enteral feeding products, often focusing on specific needs or specialized markets. The presence of diverse distribution options allows for greater flexibility and accessibility for clinicians and patients alike. As the demand for enteral access solutions continues to grow, these alternative channels will play a critical role in ensuring that products are available to those who need them, complementing the offerings of hospital and retail pharmacies.

By Ingredient Type

Silver-coated Catheters:

Silver-coated catheters are a critical innovation in the Infection Prevention and Enteral Access Market, as they are designed to reduce the risk of catheter-associated infections. The silver coating acts as an antimicrobial agent, effectively inhibiting the growth of bacteria and minimizing the likelihood of infections in patients with indwelling catheters. The increasing emphasis on infection control in healthcare settings is driving the adoption of silver-coated catheters, as healthcare providers seek to enhance patient safety and improve clinical outcomes. The growing body of evidence supporting the efficacy of these devices is expected to further bolster their market presence.

Silicone Feeding Tubes:

Silicone feeding tubes are widely used in enteral feeding due to their biocompatibility, flexibility, and comfort for patients. These tubes are designed for long-term use and are less likely to cause irritation or adverse reactions compared to other materials. The rising prevalence of conditions requiring enteral feeding, such as neurological disorders and cancers, is driving the demand for silicone feeding tubes. As healthcare providers increasingly prioritize patient comfort and safety, silicone feeding tubes are becoming the preferred choice for enteral feeding applications, contributing to their growing market share.

Polyurethane Feeding Tubes:

Polyurethane feeding tubes are another important category in the Infection Prevention and Enteral Access Market, known for their durability and strength. These tubes are often utilized in situations where a more rigid structure is required, enabling efficient delivery of nutrition to patients with specific needs. The growing acceptance of polyurethane feeding tubes in clinical settings is fueled by advancements in manufacturing techniques that enhance their performance and reduce complications associated with feeding tube use. As healthcare providers continue to seek reliable solutions for enteral feeding, the demand for polyurethane feeding tubes is anticipated to grow.

Standard Formulas:

Standard enteral feeding formulas are designed to meet the nutritional needs of a broad range of patients requiring enteral nutrition. These formulas provide a balanced mix of macronutrients, vitamins, and minerals, ensuring that patients receive the essential nutrients necessary for recovery and overall health. The increasing awareness of the importance of nutritional support in patient care is driving the demand for standard formulas. As healthcare professionals emphasize the role of nutrition in improving clinical outcomes, standard enteral feeding formulas are becoming a fundamental part of treatment protocols in various healthcare settings.

Disease-specific Formulas:

Disease-specific enteral feeding formulas are tailored to meet the unique nutritional requirements of patients with specific medical conditions, such as diabetes, renal disease, or malabsorption syndromes. These specialized formulas are designed to provide targeted support to optimize health outcomes for patients facing complex dietary needs. The rising prevalence of chronic diseases and the recognition of the importance of nutrition in managing these conditions are driving the demand for disease-specific formulas. As healthcare providers increasingly utilize tailored nutritional approaches to enhance patient care, the market for disease-specific enteral feeding formulas is expected to experience significant growth.

By Region

The North American region dominates the Infection Prevention and Enteral Access Market, accounting for a significant share of the global market due to the well-established healthcare infrastructure, high awareness of infection control practices, and advanced medical technology. The increasing prevalence of chronic diseases and the aging population further fuel the demand for enteral feeding solutions in this region. For instance, the North American market is projected to grow at a CAGR of approximately 8% through 2035, driven by ongoing innovations in product development and the rising focus on patient safety. Major players in the region are continually investing in research and development to enhance the efficacy and safety of enteral access devices, further solidifying North America's position as a leader in this market.

Europe is also a key region for the Infection Prevention and Enteral Access Market, with a substantial share attributed to the growing number of hospitals and long-term care facilities implementing stringent infection control measures. The European market is characterized by an increasing focus on patient-centered care, which has led to greater adoption of enteral feeding solutions. The market in Europe is expected to witness a CAGR of around 7% during the forecast period, driven by the rising demand for antimicrobial devices and advanced enteral access products. As healthcare systems continue to evolve, the increasing importance of nutritional support in improving patient outcomes is anticipated to shape market growth in this region.

Opportunities

There are significant opportunities for growth in the Infection Prevention and Enteral Access Market, particularly within emerging economies where healthcare infrastructure is rapidly developing. As these regions expand their healthcare capabilities, the demand for enteral feeding solutions is expected to rise. Companies that focus on developing affordable, high-quality products tailored to the unique needs of these markets can capitalize on the rising healthcare spending and increasing prevalence of chronic diseases. Additionally, partnerships with local healthcare providers and distributors can help ensure that products are effectively reaching the intended audience, thereby increasing market penetration and fostering brand loyalty.

Moreover, there is a growing trend towards personalized medicine, where treatment approaches are tailored to individual patient needs. This shift presents an opportunity for manufacturers to develop customized enteral feeding solutions that cater to specific medical conditions and dietary requirements. By investing in research and development to create innovative products and formulations, companies can differentiate themselves in the competitive market. Furthermore, as the aging population continues to increase globally, the demand for enteral feeding solutions will likely grow, presenting an ongoing opportunity for market expansion in both established and emerging markets.

Threats

Despite the significant growth potential in the Infection Prevention and Enteral Access Market, several threats could hinder progress. One major concern is the potential for regulatory challenges and stringent compliance requirements that may affect product approvals and market entry. As healthcare regulations continue to evolve, manufacturers must navigate complex processes to ensure that their products meet safety standards and gain necessary certifications. Non-compliance with these regulations can lead to delays in product launches, increased costs, and potential liability issues, ultimately impacting a company's market position and profitability.

Additionally, competition within the market is intensifying, with numerous players vying for market share. Price wars and aggressive marketing strategies can erode profit margins, making it imperative for companies to constantly innovate and differentiate their offerings. The growing trend of consolidation among healthcare providers may also affect the purchasing power of enteral access products, as larger entities may negotiate lower prices, further squeezing margins for manufacturers. In this dynamic market landscape, companies must remain agile and responsive to changing market conditions to sustain their competitive advantage.

Competitor Outlook

• Medtronic
• Abbott Laboratories
• Boston Scientific Corporation
• Teleflex Incorporated
• Cardinal Health
• Halyard Health
• BD (Becton, Dickinson and Company)
• Fresenius Kabi
• Nutricia (Part of Danone)
• Cook Medical
• Smiths Medical
• ConvaTec Group PLC
• Medline Industries
• Moog Inc.
• Sorenson Medical

The competitive landscape of the Infection Prevention and Enteral Access Market is characterized by a diverse range of players, from established multinational corporations to innovative startups. This market is marked by both product innovation and strategic collaborations, as companies seek to enhance their product offerings and market reach. Major players are investing heavily in research and development to create advanced enteral feeding devices and accessories that address the evolving needs of patients and healthcare providers. Furthermore, partnerships and alliances between manufacturers and healthcare providers are becoming increasingly common, as stakeholders work together to improve patient outcomes and promote the adoption of enteral access solutions.

Among the key players in the market, Medtronic stands out for its comprehensive portfolio of enteral feeding devices and infection prevention products. The company leverages its extensive research capabilities to develop cutting-edge solutions that enhance patient safety and improve clinical outcomes. Similarly, Abbott Laboratories is recognized for its innovative nutritional products, including specialized enteral feeding formulas that cater to patients with specific dietary needs. These companies are continually expanding their product lines and investing in emerging technologies to stay competitive in the market.

Boston Scientific Corporation and Teleflex Incorporated are also significant competitors, known for their advanced medical devices designed to minimize infection risks associated with enteral access. Both companies focus on enhancing product safety and usability, ensuring that their offerings align with the growing emphasis on infection prevention in healthcare settings. As the market continues to evolve, these major players will likely play a crucial role in shaping the future landscape of the Infection Prevention and Enteral Access Market through innovation, strategic partnerships, and a commitment to improving patient care.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Medtronic
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Moog Inc.
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Cook Medical
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Fresenius Kabi
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Halyard Health
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Smiths Medical
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Cardinal Health
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Sorenson Medical
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 ConvaTec Group PLC
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Medline Industries
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Abbott Laboratories
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Teleflex Incorporated
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Nutricia (Part of Danone)
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Boston Scientific Corporation
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 BD (Becton, Dickinson and Company)
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Infection Prevention and Enteral Access Market, By Application
    • 6.1.1 Hospitals
    • 6.1.2 Ambulatory Surgical Centers
    • 6.1.3 Long-term Care Facilities
    • 6.1.4 Home Care Settings
    • 6.1.5 Clinics
  • 6.2 Infection Prevention and Enteral Access Market, By Product Type
    • 6.2.1 Antimicrobial Catheters
    • 6.2.2 Enteral Feeding Pumps
    • 6.2.3 Enteral Feeding Tubes
    • 6.2.4 Enteral Feeding Accessories
    • 6.2.5 Enteral Feeding Formulas
  • 6.3 Infection Prevention and Enteral Access Market, By Ingredient Type
    • 6.3.1 Silver-coated Catheters
    • 6.3.2 Silicone Feeding Tubes
    • 6.3.3 Polyurethane Feeding Tubes
    • 6.3.4 Standard Formulas
    • 6.3.5 Disease-specific Formulas
  • 6.4 Infection Prevention and Enteral Access Market, By Distribution Channel
    • 6.4.1 Hospitals Pharmacies
    • 6.4.2 Retail Pharmacies
    • 6.4.3 Online Pharmacies
    • 6.4.4 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Infection Prevention and Enteral Access Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Infection Prevention and Enteral Access market is categorized based on

By Product Type

• Antimicrobial Catheters
• Enteral Feeding Pumps
• Enteral Feeding Tubes
• Enteral Feeding Accessories
• Enteral Feeding Formulas

By Application

• Hospitals
• Ambulatory Surgical Centers
• Long-term Care Facilities
• Home Care Settings
• Clinics

By Distribution Channel

• Hospitals Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Others

By Ingredient Type

• Silver-coated Catheters
• Silicone Feeding Tubes
• Polyurethane Feeding Tubes
• Standard Formulas
• Disease-specific Formulas

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Medtronic
• Abbott Laboratories
• Boston Scientific Corporation
• Teleflex Incorporated
• Cardinal Health
• Halyard Health
• BD (Becton, Dickinson and Company)
• Fresenius Kabi
• Nutricia (Part of Danone)
• Cook Medical
• Smiths Medical
• ConvaTec Group PLC
• Medline Industries
• Moog Inc.
• Sorenson Medical